Cite
HARVARD Citation
Park, S. et al. (2016). Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. Journal of infection. 73 (5), pp. 496-505. [Online].